Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small ...

Women in midlife face a difficult trade-off. Many in their 40s to 60s face a high risk of breast cancer, especially during ...

Data from a Phase I trial of Avmapki Fakzynja also supports the regimen's tolerability and suggests its potential activity in ...